Home NDC 0093-4175 Cephalexin
Product NDC 0093-4175
11-digit product format 000934175
Labeler code 0093
Product ID 0093-4175_c75c0bb6-fe3e-43c6-bdde-edd904731795
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Cephalexin
Dosage form POWDER, FOR SUSPENSION
Route ORAL
Labeler Teva Pharmaceuticals USA, Inc.
Application ANDA062703
Marketing category ANDA
Marketing start 1990-09-30
Substance CEPHALEXIN
Active strength 125 mg/5mL
Pharmacologic classes Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A062703-001 CEPHALEXIN CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 A062703-002 CEPHALEXIN CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 84 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A062703-001 CEPHALEXIN EQ 125MG BASE/5ML FOR SUSPENSION / ORAL AB 1987-02-13 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 A062703-002 CEPHALEXIN EQ 250MG BASE/5ML FOR SUSPENSION / ORAL AB RS 1987-02-13 bb7c543d1eb4…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 84 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Cephalexin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEPHALEXIN 125 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination OBN7UDS42Y Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 309110 Internal RxNorm lookup 309112 Internal RxNorm lookup 309113 Internal RxNorm lookup 309114 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0093-4175-73 Cephalexin 100 mL in 1 BOTTLE POWDER, FOR SUSPENSION 100 26 0093-4175-74 Cephalexin 200 mL in 1 BOTTLE POWDER, FOR SUSPENSION 200 26
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 ALUMINUM OXIDE INACTIVE INGREDIENT LMI26O6933 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 FERROSOFERRIC OXIDE INACTIVE INGREDIENT XM0M87F357 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 GELATIN INACTIVE INGREDIENT 2G86QN327L CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 HYPROMELLOSE 2910 (3 MPA.S) INACTIVE INGREDIENT 0VUT3PMY82 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 HYPROMELLOSE 2910 (6 MPA.S) INACTIVE INGREDIENT 0WZ8WG20P6 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 MALTODEXTRIN INACTIVE INGREDIENT 7CVR7L4A2D CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 POLYETHYLENE GLYCOL 400 INACTIVE INGREDIENT B697894SGQ CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 PROPYLENE GLYCOL INACTIVE INGREDIENT 6DC9Q167V3 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 SODIUM LAURYL SULFATE INACTIVE INGREDIENT 368GB5141J CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 SUCROSE INACTIVE INGREDIENT C151H8M554 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION CEPHALEXIN TABLET [TEVA PHARMACEUTICALS USA INC] 13 CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 CEPHALEXIN ACTIVE INGREDIENT OBN7UDS42Y CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 CEPHALEXIN ACTIVE MOIETY OBN7UDS42Y CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 CEPHALEXIN ANHYDROUS ACTIVE MOIETY 5SFF1W6677 CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 BENZYL ALCOHOL INACTIVE INGREDIENT LKG8494WBH CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 MALTODEXTRIN INACTIVE INGREDIENT 7CVR7L4A2D CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 MALTODEXTRIN INACTIVE INGREDIENT 7CVR7L4A2D CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 SILICON DIOXIDE INACTIVE INGREDIENT ETJ7Z6XBU4 CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 SODIUM BENZOATE INACTIVE INGREDIENT OJ245FE5EU CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 SUCROSE INACTIVE INGREDIENT C151H8M554 CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE CEPHALEXIN POWDER, FOR SUSPENSION [REBEL DISTRIBUTORS CORP] 1 XANTHAN GUM INACTIVE INGREDIENT TTV12P4NEE CEPHALEXIN POWDER, FOR SUSPENSION [PREFERRED PHARMACEUTICALS, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0093-4175 CEPHALEXIN CAPSULE CEPHALEXIN POWDER, FOR SUSPENSION [TEVA PHARMACEUTICALS USA, INC.] 26 Current NDC, Legacy NDC, 2 package rows 20220316_19307ff0-71de-477b-965d-ea243e5ede3a.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0093-4175-73 00093417573 100 mL in 1 BOTTLE (0093-4175-73) 100 ml 1990-09-30 0000-00-00 No No Current 0093-4175-74 00093417574 200 mL in 1 BOTTLE (0093-4175-74) 200 ml 1990-09-30 0000-00-00 No No Current